featured
Oral Orexin Receptor 2 Agonist Therapy for Narcolepsy Type 1
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Oral Orexin Receptor 2 Agonist in Narcolepsy Type 1
N. Engl. J. Med 2023 Jul 27;389(4)309-321, Y Dauvilliers, E Mignot, R Del Río Villegas, Y Du, E Hanson, Y Inoue, H Kadali, E Koundourakis, S Meyer, R Rogers, TE Scammell, SI Sheikh, T Swick, Z Szakács, P von Rosenstiel, J Wu, H Zeitz, NV Murthy, G Plazzi, C von HehnFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.